CATABASIS PHARMACEUTICALS INC 4
4 · CATABASIS PHARMACEUTICALS INC · Filed Feb 10, 2017
Insider Transaction Report
Form 4
Cunnane Deirdre A.
SVP, General Counsel
Transactions
- Award
Stock Option (right to buy)
2017-02-09+100,000→ 100,000 totalExercise: $1.24Exp: 2027-02-08→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 9, 2017 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 9, 2017 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.